Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 1351

A British consortium with funding from the UK government has successfully tested what it calls “un-jammable” quantum navigation tech in flight.

Geopolitical tensions and warfare have introduced GPS jamming as a means of messing with enemy communication and navigation. This can cause disturbances for both military and civilian transportation and location services.

The quantum-based navigation system is called Positioning, Navigation, and Timing (PNT). Its developers are quantum technology firm Infleqtion’s UK subsidiary in collaboration with aerospace company BAE Systems and defence tech contractor QinetiQ, among others.

Read more | >

From Stanford TRANSIC: Sim-to-Real Policy Transfer by Learning from Online Correction.

From Stanford.

TRANSIC: Sim-to-Real Policy Transfer by Learning from Online Correction.

Learning in simulation and transferring the learned policy to the real world has the potential to enable generalist robots.

Continue reading “TRANSIC: Sim-to-Real Policy Transfer by Learning from Online Correction” | >

A quantum internet would essentially be unhackable. In the future, sensitive information—financial or national security data, for instance, as opposed to memes and cat pictures—would travel through such a network in parallel to a more traditional internet.

Of course, building and scaling systems for quantum communications is no easy task. Scientists have been steadily chipping away at the problem for years. A Harvard team recently took another noteworthy step in the right direction. In a paper published this week in Nature, the team says they’ve sent entangled photons between two quantum memory nodes 22 miles (35 kilometers) apart on existing fiber optic infrastructure under the busy streets of Boston.

“Showing that quantum network nodes can be entangled in the real-world environment of a very busy urban area is an important step toward practical networking between quantum computers,” Mikhail Lukin, who led the project and is a physics professor at Harvard, said in a press release.

Read more | >

A substantial proportion of people with a traumatic brain injury who had their life support withdrawn may have survived and at least partially recovered, a study suggests.

Traumatic brain injuries can occur due to a forceful blow, a jolt to the head or an object entering the brain, such as a bullet…

After comparing people with brain injuries whose life support was continued with those who had it turned off, scientists calculated that around 40 per cent in the latter group may have made some recovery.

By Moheb Costandi

Continue reading “Some brain injury patients would recover if life support weren’t ended” | >

In an amazing phenomenon of quantum physics known as tunneling, particles appear to move faster than the speed of light. However, physicists from Darmstadt believe that the time it takes for particles to tunnel has been measured incorrectly until now. They propose a new method to stop the speed of quantum particles.

In classical physics, there are hard rules that cannot be circumvented. For example, if a rolling ball does not have enough energy, it will not get over a hill, but will turn around before reaching the top and reverse its direction. In quantum physics, this principle is not quite so strict: a particle may pass a barrier, even if it does not have enough energy to go over it. It acts as if it is slipping through a tunnel, which is why the phenomenon is also known as quantum tunneling. What sounds magical has tangible technical applications, for example in flash memory drives.

In the past, experiments in which particles tunneled faster than light drew some attention. After all, Einstein’s theory of relativity prohibits faster-than-light velocities. The question is therefore whether the time required for tunneling was “stopped” correctly in these experiments. Physicists Patrik Schach and Enno Giese from TU Darmstadt follow a new approach to define “time” for a tunneling particle. They have now proposed a new method of measuring this time. In their experiment, they measure it in a way that they believe is better suited to the quantum nature of tunneling.

Read more | >

The first and the best-known metallocene is ‘ferrocene’, which contains a single iron atom. Sandwich complexes are now standard topics in inorganic chemistry textbooks, and the bonding and electronic structure of metallocenes are covered in undergraduate chemistry courses. These sandwich molecules are also significant in industry, where they serve as catalysts and are utilized in the creation of unique metallopolymers.

Nobody knows exactly how many sandwich molecules there are today, but the number is certainly in the thousands. And they all have one thing in common: a single metal atom located between two flat rings of carbon atoms. At least that was what was thought up until 2004, when a research group from the University of Seville made a startling discovery.

The Spanish research team succeeded in synthesizing a sandwich molecule that contained not one but two metal atoms. For a long time, this ‘dimetallocene’ containing two zinc atoms remained the only example of its kind until a group in the UK succeeded last year in synthesizing a very similar molecule that contained two beryllium atoms. But now, Inga Bischoff, a doctoral student in Dr. André Schäfer’s research team at Saarland University, has taken things one big step further. She has managed to synthesize in the laboratory the world’s first ‘heterobimetallic’ sandwich complex – a dimetallocene that contains two different metal atoms.

Read more | >

Jason Comander, MD, PhD, performs the procedure to deliver the CRISPR-based medicine as part of the BRILLIANCE trial in September 2020 at Mass Eye and Ear. Credit: Mass Eye and Ear.

All 14 trial participants, including 12 adults (ages 17 to 63) and two children (ages 10 and 14), were born with a form of Leber Congenital Amaurosis (LCA) caused by mutations in the centrosomal protein 290 (CEP290) gene. They underwent a single injection of a CRISPR/Cas9 genome editing medicine, EDIT-101 in one eye via a specialized surgical procedure. This trial, which included the first patient to ever receive a CRISPR-based investigational medicine directly inside the body, focused primarily on safety with a secondary analysis for efficacy.

No serious treatment or procedure-related adverse events were reported, nor were there any dose-limiting toxicities. For efficacy, the researchers looked at four measures: best-corrected visual acuity (BCVA); dark-adapted full-field stimulus testing (FST), visual function navigation (VNC, as measured by a maze participants completed), and vision-related quality of life.

Read more | >